Keyphrases
2′-fucosyllactose (2′-FL)
43%
Ad Libitum
43%
Bacterial Adhesion
16%
Bacterial Infection
43%
Bacteroides
59%
Body Growth
43%
Cesarean
15%
Diarrhea
43%
Dietary Fiber Intake
15%
Dietary Weight Loss
43%
Donor Human Milk
43%
Enterotype
43%
Escherichia Coli F18
43%
Fasting Plasma Glucose
16%
Fecal Microbiota Transplantation
43%
Glucose Metabolism
46%
Gut Colonization
43%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
15%
Host Response
43%
Intestinal Function
43%
Intestinal Structure
43%
Metabolic Improvement
43%
Milk
43%
Mucosa
16%
Newborn pigs
43%
Obesity Management
46%
Overweight Adults
43%
Pasteurization
43%
Personalized nutrition
50%
Pig Feed
28%
Preterm pigs
86%
Prevotella
100%
Prognostic Marker
43%
Psycho
43%
Randomized Controlled Trial
43%
Route of Administration
43%
Weight Loss
58%
Weight Loss Success
43%
Weight Maintenance
43%
Whole Grain
43%
Medicine and Dentistry
Alanine Aminotransferase
21%
Bacteroides
64%
Biological Marker
22%
Body Weight
15%
Body Weight Loss
43%
Cardiovascular Disease
21%
Diarrhea
43%
Escherichia coli
43%
Fluorine-18
43%
Glucose Metabolism
43%
Gut Microbiota
32%
High Density Lipoprotein Cholesterol
21%
Homeostatic Model Assessment
15%
Intestine Function
43%
Low Density Lipoprotein Cholesterol
21%
Low Fat Diet
21%
Maturity Onset Diabetes of the Young
21%
Metabolic Syndrome
21%
Neonatal Infant
43%
Nutrition
47%
Obesity
21%
Obesity Management
43%
Prevotella
64%
Triacylglycerol
21%
Immunology and Microbiology
Alanine Aminotransferase Level
21%
Bacterium Adherence
25%
Body Weight Loss
43%
Cholesterol Blood Level
21%
Escherichia coli
43%
Feces microflora
46%
High-Density Lipoprotein
21%
Immune Response
43%
Infectious Agent
21%
Intestine Function
43%
Low-Density Lipoprotein
21%
Mucosa
20%
Prevotella
48%
Small Intestine
21%
